“…Variable to poor results have been obtained with curettage and electrodessication (117–120). Cautery may compromise histologic interpretation and may delay healing (121).…”
Lentigo maligna (LM), a melanoma in situ, is a fairly common melanocytic lesion that usually develops on the chronically sun-exposed skin of the head and neck of Caucasians. It occurs mostly in people older than 40 years, with an incidence rate that increases with age and peaks in the seventh and eighth decades of life. Its diagnosis and treatment remain challenging. In this article, we review the history, epidemiology, clinical presentation, histology, and treatment of LM.
“…Variable to poor results have been obtained with curettage and electrodessication (117–120). Cautery may compromise histologic interpretation and may delay healing (121).…”
Lentigo maligna (LM), a melanoma in situ, is a fairly common melanocytic lesion that usually develops on the chronically sun-exposed skin of the head and neck of Caucasians. It occurs mostly in people older than 40 years, with an incidence rate that increases with age and peaks in the seventh and eighth decades of life. Its diagnosis and treatment remain challenging. In this article, we review the history, epidemiology, clinical presentation, histology, and treatment of LM.
“…Nonetheless, there is a high relapse rate and one author has put this as high as 25% (Beeson and McDermott, 1971). Fatal cases can occur and a mortality as high as 18% has been calculated by some (Costello, 1947). An early account of fatalities was given in 1959 (Forman, 1959) and since then isolated reports have added to the list.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.